Novanta
Precision motion, laser, robotics and surgical technologies for medical and industrial equipment makers.
Something off on this page? Send us feedback.
Profile
Supplies precision components, subsystems and surgical consumables to medical, life science and advanced-industrial OEMs through Automation Enabling Technologies and Medical Solutions. Revenue comes mainly from engineered placements in long-life equipment platforms, with meaningful exposure to a small number of medical customers.
Supplies precision components, subsystems and consumables to medical, life science and advanced-industrial equipment makers. Automation Enabling Technologies spans laser beam steering and sources, robotic and precision motion, end-of-arm tooling and air-bearing spindles. Medical Solutions covers insufflators, endoscopic pumps and disposables, imaging and RFID, motion control, light engines and integrated operating-room systems; Riverpoint adds surgical fibers and related minimally invasive consumables.
Wins long-cycle OEM placements by tailoring proprietary hardware and software to demanding applications, then sells mainly through technical direct-sales teams. Operations and customers span North America, Europe and Asia, with manufacturing distributed across those regions.
Revenue depends on OEM design cycles, hospital and industrial capital spending, medical-device regulation and acquisition integration. A small number of medical OEM customers account for a meaningful share of sales.
Company facts
Categories
Key statistics
Year to date +28.0% · Average volume (30d) 407.0K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Robert W. Baird | Target | $180 | $194 | ||
| Jun 9, 2026 | Robert W. Baird | Target | $150 | $180 | ||
| Mar 30, 2026 | Baird | Upgrade | Neutral | Outperform | ||
| Feb 25, 2026 | Robert W. Baird | Target | $160 | $150 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q2 FY26 | $0.83 | $0.89 | +7.2% | $262.3M | $265.8M | +1.3% | +6.66% |
| May 11, 2026Q1 FY26 | $0.78 | $0.81 | +3.8% | $253.4M | $257.7M | +1.7% | +13.72% |
| Feb 23, 2026Q4 FY25 | $0.88 | $0.91 | +3.4% | $255.6M | $258.3M | +1.1% | −3.47% |
| Nov 3, 2025Q3 FY25 | $0.81 | $0.87 | +7.4% | $255.6M | $247.8M | −3.0% | −4.81% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $233.4M | $241.0M | $247.8M | $258.3M | $257.7M | $265.8M | |
| Gross profit | $98.8M | $99.9M | $104.0M | $105.1M | $107.8M | $120.9M | |
| Operating income | $30.0M | $27.5M | $28.5M | $30.7M | $30.1M | $18.1M | |
| Net income | $21.2M | $4.5M | $10.7M | $17.5M | $21.1M | $12.5M | |
| Diluted EPS | $0.59 | $0.12 | $0.30 | $0.45 | $0.51 | $0.30 | |
| Gross margin | 42.3% | 41.4% | 42.0% | 40.7% | 41.8% | 45.5% | |
| Operating margin | 12.8% | 11.4% | 11.5% | 11.9% | 11.7% | 6.8% |
Fiscal years (4-quarter sums)FY21 $706.8M · FY22 $860.9M · FY23 $881.7M · FY24 $949.2M · FY25 $980.6M
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jul 3, 2026Cash & short-term investments $718.7M · Total debt $282.8M · Total assets $2.14B · Shareholders' equity $1.62B
Dividends
No dividends on record.
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 35.61M · Float 35.34M · 99.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 4.80M | 13.47% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 2.40M | 6.73% | 13F | Aug 13, 2026 |
| Price T Rowe Associates Inc /MD/ | 2.22M | 6.24% | 13F | Aug 14, 2026 |
| T. Rowe Price Associates, Inc. | 2.22M | 6.20% | 13G | Aug 14, 2026 |
| Allspring Global Investments Holdings, LLC | 1.82M | 5.10% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Jul 2, 2026 | Matthijs Glastra | director, officer: Chief Executive Officer | −6,500 | $161.13 |
| Jun 2, 2026 | Matthijs Glastra | director, officer: Chief Executive Officer | −6,500 | $168.66 |
| May 12, 2026 | Matthijs Glastra | director, officer: Chief Executive Officer | −7,500 | $150.43 |
| May 5, 2026 | Matthijs Glastra | director, officer: Chief Executive Officer | −6,500 | $131.13 |
| Apr 17, 2026 | Matthijs Glastra | director, officer: Chief Executive Officer | −6,500 | $130.05 |
Peers
- MKS
Broad photonics and motion overlap in industrial OEM subsystems
- Coherent
Laser and optics scale competitor across precision applications
- Stryker
Surgical visualization and insufflation rival in the OR
- Zebra Technologies
RFID, barcode, and machine-vision overlap in asset automation
- Cognex
Machine vision and barcode rival in automation workflows
- Teledyne Technologies
Imaging, sensors, and instrumentation peer for OEM systems
- Allient
Precision motion rival in medical and industrial equipment
- IPG Photonics
Fiber-laser specialist competing in laser-source niches
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Novanta | $142.20 | −0.07% | $5.06B | 91.2 | 35.6 | 4.9 | +10.3% |
| MKS | $256.50 | +0.31% | $17.28B | 40.8 | 16.3 | 4.0 | +28.3% |
| Coherent | $279.00 | −0.02% | $54.62B | 67.9 | 29.8 | 7.7 | +33.7% |
| Stryker | $334.18 | +1.06% | $126.77B | 34.3 | 20.6 | 4.9 | +9.4% |
| Zebra Technologies | $356.45 | +0.03% | $16.98B | 33.5 | 17.2 | 2.9 | +20.4% |
| Cognex | $61.00 | +0.93% | $10.06B | 58.7 | 32.9 | 9.2 | +16.9% |
| Teledyne Technologies | $621.96 | +0.02% | $28.83B | 30.0 | 24.4 | 4.5 | +9.8% |
| Allient | $92.86 | −0.01% | $1.58B | 54.6 | 30.3 | 2.7 | +10.2% |
| IPG Photonics | $76.53 | +0.01% | $3.25B | 117.7 | 40.4 | 3.0 | +11.1% |
| Median | 47.7 | 27.1 | 4.2 | +14.0% |